title: ADAP faces financial abyss. AIDS Drug Assistance Programs.
authors.forename: D
authors.initials: D
authors.lastname: Link
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D004279:DNA, Viral / Q000097:blood; D016527:Drug Costs; D004359:Drug Therapy, Combination; D004608:Eligibility Determination; D005569:Formularies as Topic; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D008119:Lobbying; D008484:Medicaid / Q000706:statistics & numerical data; D013221:State Health Plans; D014481:United States
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D017320:HIV Protease Inhibitors